Bicyclic-fused heteroaryl or aryl compounds
US-12202836-B2 · Jan 21, 2025 · US
This page is not indexed by search engines while we improve data quality.
Saiah Eddine patents
Saiah Eddine is listed as an inventor on 38 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Saiah Eddine |
| Total patents | 38 |
| First publication | Oct 8, 2015 |
| Latest publication | Jan 21, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Rapamycin analogs and uses thereof
US-2024173305-A1 · May 30, 2024 · US
Rapamycin analogs and uses thereof
US-2024139164-A1 · May 2, 2024 · US
Rapamycin analogs and uses thereof
US-2024131012-A1 · Apr 25, 2024 · US
Rapamycin analogs and uses thereof
US-11944605-B2 · Apr 2, 2024 · US
Rapamycin analogs and uses thereof
US-11819476-B2 · Nov 21, 2023 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2023339960-A1 · Oct 26, 2023 · US
Bicyclic-fused heteroaryl or aryl compounds
US-11702424-B2 · Jul 18, 2023 · US
Aminopyrimidinyl compounds
US-11197867-B2 · Dec 14, 2021 · US
Aminopyrimidinyl compounds
US-2021377495-A1 · Dec 2, 2021 · US
Recent patents
Latest publications not already listed above.
Aminopyrimidinyl compounds
US-10980815-B2 · Apr 20, 2021 · US
Bruton's Tyrosine Kinase Inhibitors
US-2021002251-A1 · Jan 7, 2021 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2020377511-A1 · Dec 3, 2020 · US
Bruton's tyrosine kinase inhibitors
US-10815213-B2 · Oct 27, 2020 · US
Aminopyrimidinyl compounds
US-2020330477-A1 · Oct 22, 2020 · US
Bicyclic-fused heteroaryl or aryl compounds
US-10793579-B2 · Oct 6, 2020 · US
Aminopyrimidinyl compounds
US-2020038409-A1 · Feb 6, 2020 · US
Aminopyrimidinyl compounds
US-10463675-B2 · Nov 5, 2019 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2019270751-A1 · Sep 5, 2019 · US
Bruton's Tyrosine Kinase Inhibitors
US-2019202798-A1 · Jul 4, 2019 · US
Bicyclic-fused heteroaryl or aryl compounds
US-10329302-B2 · Jun 25, 2019 · US
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
US-10316018-B2 · Jun 11, 2019 · US
Bruton's tyrosine kinase inhibitors
US-10266513-B2 · Apr 23, 2019 · US
Bicyclic-fused heteroaryl or aryl compounds as irak4 modulators
US-2019092750-A1 · Mar 28, 2019 · US
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
US-10174000-B2 · Jan 8, 2019 · US
Bicyclic-fused heteroaryl or aryl compounds as irak4 modulators
US-2018244646-A1 · Aug 30, 2018 · US
Bicyclic-Fused Heteroaryl Or Aryl Compounds
US-2018230127-A1 · Aug 16, 2018 · US
Bicyclic-Fused Heteroaryl or Aryl Compounds
US-2018127432-A1 · May 10, 2018 · US
Sepiapterin reductase inhibitors
US-9963462-B2 · May 8, 2018 · US
Bicyclic-fused heteroaryl or aryl compounds
US-9879022-B2 · Jan 30, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pfizer | 31 |
| Janssen Pharmaceutica Nv | 5 |
| Quartet Medicine Inc | 2 |
| Ecole Polytechnique Fed Lausanne Epfl | 1 |
| Max Planck Gesellschaft | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 32 |
| C07D401/14 | 32 |
| A61P35/00 | 31 |
| A61P43/00 | 31 |
| A61P37/00 | 30 |